SCHEMBL6111306

SCHEMBL6111306

C=CCc1cn(CC=C)c2ccccc12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.49
MEN1 O00255 5/20 0.47
KMT2A Q03164 5/20 0.47
PDE4B Q07343 1/20 0.47
PDE4D Q08499 1/20 0.47
NPC1 O15118 1/20 0.46
USP2 O75604 1/20 0.46
RAB9A P51151 1/20 0.46
ICMT O60725 1/20 0.43
HTR6 P50406 3/20 0.41
MAPT P10636 2/20 0.40
KDM4E B2RXH2 1/20 0.40
LMNA P02545 1/20 0.40
GAA P10253 1/20 0.40
HPGD P15428 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
ALDH1A1 P00352 1/20 0.40
CHRNB2 P17787 1/20 0.39
CHRNA7 P36544 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8335058 0.86 ALOX5 (0.49) ALOX5MEN1KMT2APDE4BPDE4D
SCHEMBL1520654 0.86 ALOX5 (0.52) ALOX5MEN1KMT2APDE4BPDE4D
SCHEMBL29092264 0.83 CYP19A1 (0.58) MEN1KMT2AHTR6MAPTLMNA
SCHEMBL15700113 0.81 POLB (0.52) ALOX5MEN1KMT2APDE4BPDE4D
SCHEMBL8758280 0.81 HTR2A (0.57) ALOX5MEN1KMT2APDE4BPDE4D
SCHEMBL2187777 0.79 CDC25A (0.59) ALOX5MEN1KMT2AICMTLMNA
SCHEMBL18967663 0.79 GPR84 (0.65) MEN1KMT2AKDM4ELMNAHPGD
SCHEMBL8088590 0.78 MEN1 (0.51) ALOX5MEN1KMT2APDE4BPDE4D
SCHEMBL632967 0.78 CDC25A (0.48) ALOX5MEN1KMT2AICMTHTR6
SCHEMBL29202658 0.78 ALOX5 (0.49) ALOX5MEN1KMT2APDE4BPDE4D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6998489-B2 Methods of making indazoles ALCON, INC. (CH) 2006-02-14 US disclosed
EP-1392659-A4 METHODS OF MAKING INDAZOLES ALCON INC (CH) 2004-10-20 EP disclosed
US-20040142998-A1 Methods of making indazoles ALCON, INC. (CH) 2004-07-22 US disclosed
EP-1392659-A1 METHODS OF MAKING INDAZOLES Alcon, Inc. (CH) 2004-03-03 EP disclosed
WO-2002098862-A1 METHODS OF MAKING INDAZOLES ALCON, INC. (CH) 2002-12-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142998-A1 Methods of making indazoles NAT1, CYP3A5, ALDH3A1 ALOX5 99/4885MEN1 3316/4885KMT2A 2228/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.